Torrent Pharmaceuticals Limited
TORNTPHARM
Pozycja w akcjach
#1201
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Cena akcji
$50.31
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$19.14B
Zmiana (1 dzień)
-0.14%
Zmiana (1 rok)
23.83%
Kraj
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategoria
Healthcare
Zyski dla Torrent Pharmaceuticals Limited (TORNTPHARM)
Zyski w Jun 2026 TTM: $316.40M
Według najnowszych raportów finansowych Torrent Pharmaceuticals Limited, obecny zysk firmy wynosi $316.40M. W roku 2024 firma osiągnęła zysk w wysokości $282.08M, wzrost w porównaniu do zysku z roku 2023, który wynosił $224.77M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Torrent Pharmaceuticals Limited od 2005 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $316.40M | 1.24% |
| 2025 | $312.51M | 10.79% |
| 2024 | $282.08M | 25.50% |
| 2023 | $224.77M | 39.18% |
| 2022 | $161.50M | -22.54% |
| 2021 | $208.49M | 32.37% |
| 2020 | $157.51M | 94.73% |
| 2019 | $80.88M | -43.43% |
| 2018 | $142.99M | -14.78% |
| 2017 | $167.79M | -52.57% |
| 2016 | $353.73M | 134.86% |
| 2015 | $150.61M | -3.94% |
| 2014 | $156.79M | 46.48% |
| 2013 | $107.04M | 51.35% |
| 2012 | $70.72M | -8.03% |
| 2011 | $76.89M | -0.54% |
| 2010 | $77.31M | 104.22% |
| 2009 | $37.86M | 1.60% |
| 2008 | $37.26M | 48.13% |
| 2007 | $25.15M | 44.18% |
| 2006 | $17.45M | 33.96% |
| 2005 | $13.02M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 457.70% |
IN
|
